Related Experiment Videos
CCM1 gene mutations in families segregating cerebral cavernous malformations
W J Davenport1, A M Siegel, J Dichgans
1Center for Research in the Neurosciences, Montreal General Hospital, and Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
Neurology
|February 27, 2001
Summary
Researchers identified 10 new mutations in the CCM1 gene, linked to cerebral cavernous malformations (CCM). These findings suggest Krit1 protein loss causes CCM, potentially implicating it as a tumor suppressor.
Area of Science:
- Genetics
- Neurology
- Vascular Biology
Background:
- Cerebral cavernous malformations (CCM) are vascular anomalies causing neurological symptoms like strokes and seizures.
- CCM can be inherited in an autosomal dominant pattern.
- Previous research linked CCM to mutations in the CCM1 gene.
Purpose of the Study:
- To identify novel mutations in the CCM1 gene in patients with cerebral cavernous malformations.
- To investigate the functional consequences of CCM1 mutations.
Main Methods:
- Genetic screening of the CCM1 gene in 29 families and 5 sporadic cases of CCM.
- Analysis of mutation effects on Krit1 mRNA and protein function.
Main Results:
- Ten new mutations in the CCM1 gene were identified.
- These mutations were predicted to cause truncation of the Krit1 mRNA.
- Findings support the hypothesis that CCM results from loss of Krit1 protein function.
Conclusions:
- Mutations in the CCM1 gene are a significant cause of cerebral cavernous malformations.
- Loss of Krit1 protein function is implicated in CCM pathogenesis.
- Krit1 may function as a tumor suppressor, suggesting a role in tumorigenesis.